Back to Overview

The competitive landscape of orthopedic forceps market is divided, and leading enterprises are accelerating their layout in high-end fields

Mar 30,2026

Summary: The latest report from Boyan Consulting shows that by 2025, the Chinese orthopedic forceps market will present a competitive pattern of "one super, two strong, and multiple tiers", with a market concentration (CR5) of 68.3%. Among them, Weigao Orthopedics ranks first with a market share of 21.7%. With a full range of product lines and extensive channel networks, its penetration rate in the field of spinal and trauma surgical forceps reaches 34.6%.
The competitive landscape of orthopedic forceps market is divided, and leading enterprises are accelerating their layout in high-end fields

The competitive landscape of orthopedic forceps market is divided, and leading enterprises are accelerating their layout in high-end fields
The latest report from Boyan Consulting shows that by 2025, the Chinese orthopedic forceps market will present a competitive pattern of "one super, two strong, and multiple tiers", with a market concentration (CR5) of 68.3%. Among them, Weigao Orthopedics ranks first with a market share of 21.7%. With a full range of product lines and extensive channel networks, its penetration rate in the field of spinal and trauma surgical forceps reaches 34.6%.

Da Bo Medical and Kangtuo Medical rank second and third with market share of 15.9% and 12.4% respectively. Da Bo Medical has acquired OrthoCare GmbH from Germany and introduced high-end reduction forceps technology, resulting in a market share of 19.2% in the field of forceps for hip and knee replacement surgery; Kangtuo Medical focuses on the research and development of titanium alloy instruments, establishing advantages in the field of minimally invasive surgery with micrometer level blade passivation technology.

In terms of foreign brands, brands such as Stryker and Johnson&Johnson still dominate the high-end market, accounting for a total of 51.3% of the high-end market share. However, their product pricing is on average 62.3% higher than that of top domestic enterprises, mainly concentrated in scientific research surgeries in tertiary hospitals in first tier cities. The industry expects that the market concentration will increase to 71.5% by 2026, and the speed of industry reshuffle will further accelerate.

Latest News

Upgraded spinal endoscopic surgical forceps to meet the needs of multiple surgical scenarios

Beijing Wanjie Tianyuan Medical Equipment Co., Ltd. recently launched an upgraded spinal endoscopic surgical instrument kit, which includes a variety of orthopedic forceps suitable for different surgical scenarios, including nucleus pulposus forceps, vertebral plate biting forceps, toothed grasping forceps and other categories, which can meet the needs of various surgical methods such as lumbar spine, cervical spine, large channel and UBE.

The new orthopedic reduction forceps have been granted patent authorization, greatly improving the convenience of operation

The China National Intellectual Property Administration recently announced that a new type of orthopedic repositioning forceps has been granted a utility model patent (authorization announcement No.: CN 220558064 U). The patent was invented by Tian Xiao and Liu Weidong, which solves the pain points of traditional repositioning forceps that require manual fixation and are inconvenient to operate, and significantly improves the surgical efficiency and treatment effect.